Abraham Ceesay

2021 - Cerevel Therapeutics Holdings

In 2021, Abraham Ceesay earned a total compensation of $5.3M as President at Cerevel Therapeutics Holdings.

Compensation breakdown

Bonus$250,000
Non-Equity Incentive Plan$172,264
Option Awards$4,499,994
Salary$335,249
Other$19,124
Total$5,276,631

Ceesay received $4.5M in option awards, accounting for 85% of the total pay in 2021.

Ceesay also received $250K in bonus, $172.3K in non-equity incentive plan, $335.2K in salary and $19.1K in other compensation.

Rankings

In 2021, Abraham Ceesay's compensation ranked 2,460th out of 12,406 executives tracked by ExecPay. In other words, Ceesay earned more than 80.2% of executives.

ClassificationRankingPercentile
All
2,460
out of 12,406
80th
Division
Manufacturing
975
out of 5,492
82nd
Major group
Chemicals And Allied Products
374
out of 2,368
84th
Industry group
Drugs
326
out of 2,089
84th
Industry
Pharmaceutical Preparations
215
out of 1,536
86th
Source: SEC filing on April 28, 2022.

Ceesay's colleagues

We found five more compensation records of executives who worked with Abraham Ceesay at Cerevel Therapeutics Holdings in 2021.

2021

N Coles

Cerevel Therapeutics Holdings

Chief Executive Officer

2021

Kathy Yi

Cerevel Therapeutics Holdings

Chief Financial Officer

2021

Raymond Sanchez

Cerevel Therapeutics Holdings

Chief Medical Officer

2021

Scott Akamine

Cerevel Therapeutics Holdings

Chief Legal Officer

2021

Mark Bodenrader

Cerevel Therapeutics Holdings

Chief Financial Officer

News

In-depth

You may also like